Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Syneos Health faces intense buyer power from large pharma clients
Crucial for accurate fraud assessment
As a mid-stage company
needing scrutiny
2024 impact: Partnerships to boost R&D
1STDIBS SWOT ANALYSIS TEMPLATE RESEARCH B_183 Syneos Health faces intense buyerDive Deeper Into the Company's Strategic Blueprint 1stdibs excels as a curated luxury marketplace with strong brand cachet and high margin listings, but faces scaling and competition risks from larger platforms and fluctuating luxury demand; our full SWOT dissects these dynamics with financial context and strategic moves. Discover the complete picture with the full report professionally formatted Word and Excel deliverables to inform investing,
US$ 89.00
US$ 145.83
US$ 99.00
US$ 187.35
US$ 1267.90
